- Home
- LFVN vs ANIX Comparison
LFVN vs ANIX Comparison
Compare LFVN & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFVN | ANIX |
|---|---|---|
| Founded | N/A | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.2M | 135.3M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | LFVN | ANIX |
|---|---|---|
| Price | $6.46 | $3.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $30.50 | $9.00 |
| AVG Volume (30 Days) | 148.9K | ★ 353.5K |
| Earning Date | 02-04-2026 | 01-09-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | ★ 143.91 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $228,877,000.00 | N/A |
| Revenue This Year | $1.54 | N/A |
| Revenue Next Year | $7.00 | N/A |
| P/E Ratio | $8.34 | ★ N/A |
| Revenue Growth | ★ 16.77 | N/A |
| 52 Week Low | $5.98 | $2.07 |
| 52 Week High | $27.38 | $5.46 |
Technical Indicators
Market Signals| Indicator | LFVN | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 39.37 | 33.85 |
| Support Level | $6.34 | $4.20 |
| Resistance Level | $6.78 | $5.46 |
| Average True Range (ATR) | 0.31 | 0.43 |
| MACD | 0.07 | -0.13 |
| Stochastic Oscillator | 17.28 | 2.77 |
Price Performance
Historical ComparisonAbout LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.